Nevertheless, our results still strongly suggest that dysregulated pol ι by c-Jun may be functioned as mutator, which provide the important clue to further clarify the hypermutagenic role of pol ι in response to other types of DNA damage agents in bladder cancers. The gene discussed is JUN; the disease is urinary bladder cancer.